Read + Share
Alric H, Amiot A, Kirchgesner J, Treton X, et al. Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But
Not Ustekinumab in Refractory Crohn's Disease. Inflamm Bowel Dis 2022;28:218-225.
PMID: 33847351
|
 |
|
Alric H, Amiot A, Kirchgesner J, Treton X, et al. Vedolizumab Clinical Decision Support Tool Predicts Efficacy of Vedolizumab But
Not Ustekinumab in Refractory Crohn's Disease. Inflamm Bowel Dis 2022;28:218-225.
PMID: 33847351
|
|
|
|